Recent advances in clearance monitoring of monoclonal antibodies in patients with inflammatory bowel diseases-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Recent advances in clearance monitoring of monoclonal antibodies in patients with inflammatory bowel diseases

Published:2021-12-02 Issue:12 Volume:14 Page:1455-1466
ISSN:1751-2433
Container-title:Expert Review of Clinical Pharmacology
language:en
Short-container-title:Expert Review of Clinical Pharmacology

Author:

Kantasiripitak Wannee¹^ORCID,Wang Zhigang¹^ORCID,Spriet Isabel¹²^ORCID,Ferrante Marc³⁴^ORCID,Dreesen Erwin¹^ORCID

Affiliation:

1. Department of Pharmaceutical and Pharmacological Sciences, Ku Leuven, Leuven, Belgium

2. Department of Pharmacy, University Hospitals Leuven, Leuven, Belgium

3. Department of Gastroenterology and Hepatology, University Hospitals Leuven, Leuven, Belgium

4. Department of Chronic Diseases and Metabolism, University of Leuven, Leuven, Belgium

Funder

Research Foundation – Flanders (FWO), Belgium

Publisher

Informa UK Limited

Subject

Pharmacology (medical),General Pharmacology, Toxicology and Pharmaceutics,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/17512433.2021.2028619

Reference94 articles.

1. Crohn's disease

2. Ulcerative colitis

3. An Update on Inflammatory Bowel Disease

4. Systematic Review of Health-related Quality of Life Measures for Inflammatory Bowel Disease

5. Recent advances in monoclonal antibody therapy in IBD: practical issues

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Optimising infliximab induction dosing to achieve clinical remission in Chinese patients with Crohn’s disease;Frontiers in Pharmacology;2024-08-27

2. Model-informed precision dosing: State of the art and future perspectives;Advanced Drug Delivery Reviews;2024-08

3. SERENE ER Analysis Part 2 SERENE‐UC: Exposure‐response Analysis of Higher Versus Standard Adalimumab Dosing Regimens for Patients with Moderately to Severely Active Ulcerative Colitis;Clinical Pharmacology in Drug Development;2024-07-02

4. SERENE ER Analysis Part 1‐SERENE CD: Exposure‐Response Analysis of Higher Versus Standard Adalimumab Dosing Regimens for Patients With Moderately to Severely Active Crohn Disease;Clinical Pharmacology in Drug Development;2024-07-02

5. Best Practice for Therapeutic Drug Monitoring of Infliximab: Position Statement from the International Association of Therapeutic Drug Monitoring and Clinical Toxicology;Therapeutic Drug Monitoring;2024-04-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3